G
Gary E. Stein
Researcher at Michigan State University
Publications - 95
Citations - 2915
Gary E. Stein is an academic researcher from Michigan State University. The author has contributed to research in topics: Methicillin-resistant Staphylococcus aureus & Vancomycin. The author has an hindex of 27, co-authored 95 publications receiving 2653 citations. Previous affiliations of Gary E. Stein include Wayne State University.
Papers
More filters
Journal ArticleDOI
Tigecycline: a critical analysis.
Gary E. Stein,William A. Craig +1 more
TL;DR: Tigecycline (GAR-936) is the first glycylcycline antibiotic to be approved by the US Food and Drug Administration, and overcomes the 2 major resistance mechansisms of tetracycline: drug-specific efflux pump acquisition and ribosomal protection.
Journal ArticleDOI
Effects of desipramine on irritable bowel syndrome compared with atropine and placebo
David S. Greenbaum,James E. Mayle,Lawrence E. Vanegeren,John A. Jerome,Joan Mayor,Ruth B. Greenbaum,Robert W. Matson,Gary E. Stein,Howard A. Dean,Nancy A. Halvorsen,Lionel W. Rosen +10 more
TL;DR: Stool frequency, diarrhea, abdominal pain, depression, and slow contractions decreased significantly more in diarrhea-predominant patients during desipramine compared with placebo and atropine treatments.
Journal ArticleDOI
Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus
TL;DR: Ceftaroline is consistently active against multidrug-resistant Streptococcus pneumoniae and Staphylococcus aureus, including methicillin-resistant, vancomycin-intermediate, linezolid- resistant, and daptomycin-nonsusceptible strains.
Journal ArticleDOI
Tigecycline: an update.
Gary E. Stein,Timothy Babinchak +1 more
TL;DR: An updated overview of tigecycline clinical studies, current microbial resistance patterns, pharmacokinetic/pharmacodynamic investigations, and safety analyses is offered.
Journal ArticleDOI
Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis
Jack D. Sobel,Doris Brooker,Gary E. Stein,Jessica L. Thomason,Daniel P. Wermeling,Blake Bradley,Louis Weinstein +6 more
TL;DR: Fluconazole administered as a single 150 mg oral dose proved to be as safe and effective as 7 days of intravaginal clotrimazole therapy for Candida vaginitis.